Cargando…
25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
Tuberculosis is second only to COVID-19 as a cause of death from a single infectious agent. In 2020, almost 10 million people were estimated to have developed tuberculosis and it caused 1·5 million deaths. Around a quarter of deaths caused by antimicrobial resistance are due to rifampicin-resistant...
Autores principales: | Dean, Anna S, Tosas Auguet, Olga, Glaziou, Philippe, Zignol, Matteo, Ismail, Nazir, Kasaeva, Tereza, Floyd, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893725/ https://www.ncbi.nlm.nih.gov/pubmed/35248168 http://dx.doi.org/10.1016/S1473-3099(21)00808-2 |
Ejemplares similares
-
Achieving universal access to rapid tuberculosis diagnostics
por: Ismail, Nazir, et al.
Publicado: (2023) -
Impact of COVID-19 on mental health in Bhutan: a way forward for action
por: Tsheten, Tsheten, et al.
Publicado: (2023) -
The impact of the COVID-19 pandemic on the global tuberculosis epidemic
por: Falzon, Dennis, et al.
Publicado: (2023) -
Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013) -
Towards digital healthy ageing: the case of Agatha and priorities moving forward
por: Gariboldi, Maria Isabella, et al.
Publicado: (2023)